eli lilly vials tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Zepbound price cut: Eli Lilly

Good stuff for partnerships with pharmacy's & increases patient access to script #1

Certain women may have extra skin that doesnt fully retract after giving birth, particularly if they have had multiples or have significantly gained weight

More serious but less common risks include pancreatitis, gallbladder problems including gallstones, kidney issues including acute kidney failure in patients who experience severe vomiting or diarrhea, changes in vision, low blood sugar especially when combined with other diabetes medications, and increased heart rate

Severe Gastrointestinal Diseases and Pancreatitis History Active or severe inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, can worsen with tirzepatide initiation due to slowed gastric motility and altered gut hormone signaling